Rapid AST for Multidrug-Resistant Pathogens
Dr. Alberto Antonelli on what matters when evaluating rapid AST in high-resistance settings
Evaluating rapid AST in high-resistance settings
In high-resistance settings, the value of rapid AST depends on more than turnaround time alone. Laboratories also need to consider whether the antimicrobials included in a panel reflect the resistance patterns and treatment options they encounter in practice. In this interview, Alberto Antonelli discusses the importance of local epidemiology, clinically relevant antimicrobial coverage, and validating new technologies with resistant strains and real clinical samples.
He also explains why testing against challenging isolates is important for understanding how a method performs in the situations where reliable susceptibility information is most needed.
This video was filmed at ESCMID Global 2026 in Munich, Germany.
